Succinimidyl 6-BOC-hydrazinonicotinate is a chemical compound characterized by its structure, which includes a succinimidyl group, a hydrazine moiety, and a BOC (tert-butyloxycarbonyl) protecting group attached to a nicotinic acid derivative. This compound is often utilized in bioconjugation and drug development due to its ability to form stable linkages with biomolecules, such as proteins and peptides. The presence of the succinimidyl group allows for efficient coupling reactions, while the BOC group serves as a protective element that can be removed under specific conditions to reveal the hydrazine functionality. This makes it particularly useful in the synthesis of hydrazone linkages, which are important in various applications, including targeted drug delivery and the development of diagnostic agents. Additionally, the nicotinic acid component may impart specific biological activities or enhance solubility, making this compound versatile in medicinal chemistry and biochemistry. Overall, its unique structural features facilitate its role in advanced chemical and biological applications.

SUCCINIMIDYL 6-BOC-HYDRAZINONICOTINATE

133081-26-2: Succinimidyl-N-Boc-Hynic, N'-(5-[2-(2,5-Dioxo-Pyrrolidin-1-Yloxy)-Acetyl]-Pyridin-2-Yl)-Hydrazinecarboxylic Acid Tert-Butyl Ester, 6-Boc-Hydrazinopyridine-3-Nhs, Hydrazinecarboxylic acid, 2-[5-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]-2-pyridinyl]-, 1,1-dimethylethyl ester

2,5-Dioxopyrrolidin-1-yl 6-(2-(tert-butoxycarbonyl)hydrazinyl)nicotinate

3-Pyridinecarboxylic acid, 6-[1-[(1,1-dimethylethoxy)carbonyl]hydrazinyl]-, 2,5-dioxo-1-pyrrolidinyl ester

2,5-Dioxopyrrolidin-1-yl 6-(2-(tert-butoxycarbonyl)-hydrazinyl)nicotinate is a diagnostic agent that binds to the receptor in the pancreas and tissues. It has been used to diagnose cancer by detecting the uptake of 2,5-dioxopyrrolidin-1-yl 6-(2-(tert-butoxycarbonyl)-hydrazinyl)nicotinate into malignant cells. 2,5-Dioxopyrrolidin-1-yl 6-(2-(tert-butoxycarbonyl)-hydrazinyl)nicotinate can be conjugated with a radioactive isotope for use as a radioactive tracer for positron emission tomography (PET).

CAS 133081-26-2: SUCCINIMIDYL 6-BOC-HYDRAZINONICOTINATE

2,5-Dioxopyrrolidin-1-yl 6-(2-(tert-butoxycarbonyl)hydrazinyl)nicotinate

Ref: 54-OR83996

3-Pyridinecarboxylic acid, 6-[1-[(1,1-dimethylethoxy)carbonyl]hydrazinyl]-, 2,5-dioxo-1-pyrrolidinyl ester

Ref: IN-DA00147Y

2,5-Dioxopyrrolidin-1-yl 6-(2-(tert-butoxycarbonyl)-hydrazinyl)nicotinate

Ref: 3D-IFA08126

2,5-Dioxopyrrolidin-1-yl 6-(2-(tert-butoxycarbonyl)hydrazinyl)nicotinate

Ref: 10-F219022